154 related articles for article (PubMed ID: 6292695)
1. Modification of dose-response curves by effector blockade and uncompetitive antagonism.
Pennefather P; Quastel DM
Mol Pharmacol; 1982 Sep; 22(2):369-80. PubMed ID: 6292695
[TBL] [Abstract][Full Text] [Related]
2. Rational design of receptor partial agonists and possible mechanisms of receptor partial activation: a theory.
Zhu BT
J Theor Biol; 1996 Aug; 181(3):273-91. PubMed ID: 8869127
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of models for analysis of radioligand binding data.
Abramson SN; McGonigle P; Molinoff PB
Mol Pharmacol; 1987 Jan; 31(1):103-11. PubMed ID: 3027522
[TBL] [Abstract][Full Text] [Related]
4. Antagonist inhibition curves and the measurement of dissociation constants.
Barlow RB; Bond SM; Bream E; Macfarlane L; McQueen DS
Br J Pharmacol; 1997 Jan; 120(1):13-8. PubMed ID: 9117087
[TBL] [Abstract][Full Text] [Related]
5. Partial agonism: mechanisms based on ligand-receptor interactions and on stimulus-response coupling.
Pliska V
J Recept Signal Transduct Res; 1999; 19(1-4):597-629. PubMed ID: 10071788
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
Ehlert FJ
Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
[TBL] [Abstract][Full Text] [Related]
7. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
Stickle D; Barber R
Mol Pharmacol; 1993 Mar; 43(3):397-411. PubMed ID: 8095693
[TBL] [Abstract][Full Text] [Related]
8. On the use of a dynamic approach to the estimation of dissociation constants for reversible competitive antagonists.
Amidon GL; Buckner CK
J Pharmacol Exp Ther; 1981 Feb; 216(2):352-6. PubMed ID: 6257889
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic explanation for the unique pharmacologic properties of receptor partial agonists.
Zhu BT
Biomed Pharmacother; 2005 Apr; 59(3):76-89. PubMed ID: 15795100
[TBL] [Abstract][Full Text] [Related]
10. Receptor reserve masks partial agonist activity of drugs in a cloned rat 5-hydroxytryptamine1B receptor expression system.
Adham N; Ellerbrock B; Hartig P; Weinshank RL; Branchek T
Mol Pharmacol; 1993 Mar; 43(3):427-33. PubMed ID: 8095694
[TBL] [Abstract][Full Text] [Related]
11. Pseudo-noncompetitive antagonism of M1, M3, and M5 muscarinic receptor-mediated Ca2+ mobilization by muscarinic antagonists.
Kukkonen JP; Näsman J; Rinken A; Dementjev A; Akerman KE
Biochem Biophys Res Commun; 1998 Feb; 243(1):41-6. PubMed ID: 9473476
[TBL] [Abstract][Full Text] [Related]
12. Investigation into the contractile response of melatonin in the guinea-pig isolated proximal colon: the role of 5-HT4 and melatonin receptors.
Lucchelli A; Santagostino-Barbone MG; Tonini M
Br J Pharmacol; 1997 Aug; 121(8):1775-81. PubMed ID: 9283717
[TBL] [Abstract][Full Text] [Related]
13. [The quantitative patterns of the modified one-center bioreceptor model].
Poltorakov AP
Zh Obshch Biol; 2000; 61(3):274-89. PubMed ID: 10863364
[TBL] [Abstract][Full Text] [Related]
14. The ligand-receptor-G-protein ternary complex as a GTP-synthase. steady-state proton pumping and dose-response relationships for beta -adrenoceptors.
Broadley KJ; Nederkoorn PH; Timmerman H; Timms D; Davies RH
J Theor Biol; 2000 Jul; 205(2):297-320. PubMed ID: 10873440
[TBL] [Abstract][Full Text] [Related]
15. Tissue response as a functional discriminator of receptor heterogeneity: effects of mixed receptor populations on Schild regressions.
Kenakin TP
Mol Pharmacol; 1992 Apr; 41(4):699-707. PubMed ID: 1569922
[TBL] [Abstract][Full Text] [Related]
16. Determining the potency and molecular mechanism of action of insurmountable antagonists.
Kenakin T; Jenkinson S; Watson C
J Pharmacol Exp Ther; 2006 Nov; 319(2):710-23. PubMed ID: 16857731
[TBL] [Abstract][Full Text] [Related]
17. A new method for estimation of agonist dissociation constants (KA): directly fitting the postinactivation concentration-response curve to a nested hyperbolic equation.
James MK; Morgan PH; Leighton HJ
J Pharmacol Exp Ther; 1989 Apr; 249(1):61-9. PubMed ID: 2540322
[TBL] [Abstract][Full Text] [Related]
18. Stimulus amplification, efficacy, and the operational model. Part II--ternary complex occupancy mechanisms.
Trzeciakowski JP
J Theor Biol; 1999 Jun; 198(3):347-74. PubMed ID: 10366491
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.
Ring PC; Seldon PM; Barnes PJ; Giembycz MA
Mol Pharmacol; 1993 Feb; 43(2):302-12. PubMed ID: 8381515
[TBL] [Abstract][Full Text] [Related]
20. A new method for estimating dissociation constants of competitive and non-competitive antagonists with no prior knowledge of agonist concentrations.
Mackay D
Br J Pharmacol; 1994 Jan; 111(1):219-26. PubMed ID: 8012700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
